ArticleScientific reports2026
Efficient design and production of glycosylated PEDV spike S1 protein.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The spike protein is a structural protein of coronaviruses and can be divided into an amino terminal S1 domain and a carboxyl terminal S2 domain. The S1 domain binds to receptors on the cell surface, so it contains major epitopes for neutralizing antibodies and is an important immunogen for vaccine development. Vaccine research and protein structure-function studies require pure protein preparations, ideally with no tag appended. In this study, we designed constructs encoding porcine epidemic diarrhea virus (PEDV) S1 protein with tissue plasminogen activator signal peptide and a Protein Select™ tag at the amino terminus. We showed the expression of PEDV S1 protein in the supernatants of mammalian cell cultures after transfection. We further showed the purification of tag-free PEDV S1 protein upon tag cleavage by the Protein Select™ resin from Cytiva. The purified PEDV S1 protein was then characterized by deglycosylation, dynamic light scattering, size-exclusion chromatography with multi-angle light scattering, one- and two-dimensional native-PAGE, and circular dichroism. The immune reactivity of the purified PEDV S1 protein to a hyper-immune serum was demonstrated in an enzyme-linked immunosorbent assay (ELISA). Taken together, we have expressed, purified, and comprehensively characterized PEDV spike S1 protein without a tag.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.